Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new hctz clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on hctz
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Status: Completed, Condition Summary: Hypertension - Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Status: Completed, Condition Summary: Hypertension - Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension
Status: Recruiting, Condition Summary: Hypertension - Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
Status: Completed, Condition Summary: Hypertension - Effect of Licorice and Hydrochlorothiazide on Plasma Potassium
Status: Recruiting, Condition Summary: Hypokalemia - Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>75) With Mild-Moderate Hypertension.
Status: Recruiting, Condition Summary: Hypertension - Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
Status: Completed, Condition Summary: Hypertension - A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension
Status: Recruiting, Condition Summary: Essential Hypertension - Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
Status: Recruiting, Condition Summary: Hypertension - Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Status: Recruiting, Condition Summary: Metabolic Syndrome - Telmisartan80/HCTZ25 Versus telmisartan80/HCTZ12.5 in Hypertension Not Responding to telmisartan80/HCTZ12.5
Status: Completed, Condition Summary: Hypertension - A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. (ATHOS Study)
Status: Completed, Condition Summary: Hypertension - A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients
Status: Recruiting, Condition Summary: Congestive Heart Failure - The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Active, not recruiting, Condition Summary: Hypertension - Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
Status: Active, not recruiting, Condition Summary: Hypertension - Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
Status: Completed, Condition Summary: Hypertension - SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
Status: Completed, Condition Summary: Hypertension; Diabetes Mellitus, Type 2 - A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Micardis HCT] Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg [Diovan HCT] Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension.
Status: Completed, Condition Summary: Hypertension - A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
Status: Completed, Condition Summary: Hypertension - Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg
Status: Completed, Condition Summary: Healthy - Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
Status: Completed, Condition Summary: Hypertension - Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Status: Completed, Condition Summary: Hypertension - A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Status: Active, not recruiting, Condition Summary: Hypertension - Candesartan Effect in Second Stage Arterial Hypertension
Status: Not yet recruiting, Condition Summary: Stage II Hypertension - Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Status: Completed, Condition Summary: Hypertension - Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
Status: Recruiting, Condition Summary: Hypertension - Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
Status: Recruiting, Condition Summary: Essential Hypertension - Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Hypertension Not Controlled on Monotherapy
Status: Active, not recruiting, Condition Summary: Hypertension - Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
Status: Recruiting, Condition Summary: Essential Hypertension - A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension
Status: Terminated, Condition Summary: Hypertension